findmyKOL

Kenneth Cusi, MD

Enriched profile

Professor of Medicine and Chief, Division of Endocrinology, Diabetes and Metabolism · University of Florida College of Medicine

ORCIDNPI
Region🇺🇸 Gainesville, FL · Southeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusType 2 Diabetes
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2013–2024

Kenneth Cusi is Professor of Medicine and Chief, Division of Endocrinology, Diabetes and Metabolism at University of Florida College of Medicine. OpenAlex indexes 379 publications with 55,953 citations (h-index 97); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory. Clarivate lists Kenneth Cusi as a Highly Cited Researcher (Clinical Medicine, 2023).

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Kenneth Cusi, MD, is Professor of Medicine and Chief, Division of Endocrinology, Diabetes and Metabolism at University of Florida College of Medicine, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Gainesville, FL. The public record shows 379 publications with 55,953 citations (h-index 97), centered on Type 2 Diabetes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 17 companies, 3 NIH-funded awards (2013–2024).

  • Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
  • Top research focus: Type 2 Diabetes
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
NASH / NAFLD / MASH6 trialsNon-alcoholic Fatty Liver Disease6 trialsFatty Liver6 trialsFatty Liver, Alcoholic6 trialsType 2 Diabetes5 trials

Research focus

OpenAlex concept fingerprint
Type 2 Diabetes

Drugs & molecules

across trials, industry payments and publications
Invokanageneric · CanagliflozinClinical trialsIndustry payments1Publications1Ozempicgeneric · SemaglutideClinical trialsIndustry payments1PublicationsXareltogeneric · RivaroxabanClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trialsIndustry payments38Novo Nordisk IncClinical trialsIndustry payments27

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
379publications

Distinct works indexed by OpenAlex, matched via ORCID; 48 in PubMed.

55,953citations

Total citations across indexed works.

97h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2013–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Thiazolidinedione52.2%
    Pioglitazone Hcl100%
    Part D<11 patients
    SGLT2 inhibitor47.8%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B), 20230% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 20132024 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/kenneth-cusi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/kenneth-cusi-6403ba2a5

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Kenneth-Cusi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/reel/DH3W65-grST

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    surfingmash.com/surfer/dr-kenneth-cusi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surfingmash.com
  • Other

    cardiometabolichealth.org/faculty/kenneth-cusi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship in Endocrinology

    Diabetes and Metabolism, Baylor College of Medicine, Houston, TX

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.medicine.ufl.edu
  • MD

    Universidad de Buenos Aires School of Medicine

    1984
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.medicine.ufl.edu
  • Residency

    Center of Medical Education & Clinical Research (CEMIC), Buenos Aires, Argentina

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org
  • Board Certified

    Internal Medicine, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.medicine.ufl.edu
  • Board Certified

    Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.medicine.ufl.edu
  • Fellow

    American College of Physicians (FACP)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org
  • Fellow

    American Association of Clinical Endocrinologists (FACE)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org

Editorial & leadership roles

journal and society appointments
  • Co-Chair

    AACE 2022 Clinical Practice Guideline task force for Diagnosis and Management of Nonalcoholic Fatty Liver Disease

    2022
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pro.aace.com
  • Guest Editor

    Diabetes Spectrum (American Diabetes Association)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org
  • Associate editor/reviewer for multiple endocrinology

    diabetes, and liver disease journals

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Chief of Endocrinology/Diabetes

    Malcom Randall VA Medical Center, Gainesville, FL

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org
  • Prior faculty (1992–2011)

    Diabetes Division, University of Texas Health Science Center at San Antonio (UTHSCSA) and South Texas Veterans Health Care System

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrinology.medicine.ufl.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.